Medicare Part D Cost-Sharing Parameters To Be Set By CMS Under Proposal
Executive Summary
The Centers for Medicare and Medicaid Services is proposing to set annual limits on drug cost sharing required by Medicare Part D and Medicare Advantage plans, according to a proposed rule released by the agency Oct. 9
You may also be interested in...
PhRMA Targets High Cost-Sharing For Drugs In Comments To CMS
The Pharmaceutical Research and Manufacturers of America is highlighting the negative impact high cost-sharing can have on patient access to drugs, most recently in comments on the draft 2010 "call letter" for Part D plans
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials